LEAPFROG Trademark

Trademark Overview


On Wednesday, July 6, 2022, a trademark application was filed for LEAPFROG with the United States Patent and Trademark Office. The USPTO has given the LEAPFROG trademark a serial number of 79353163. The federal status of this trademark filing is REGISTERED as of Tuesday, April 16, 2024. This trademark is owned by Leapfrog Remedies Ltd. The LEAPFROG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the prevention and treatment of iron disorders, allergies, skin disorders, immune system related diseases and disorders; Pharmaceuticals preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, herpetological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders in domestic animals; Antibacterial preparations for human absorption and consumption, namely, antibacterial pharmaceuticals, antibacterial spray, antibacterial substance for medical purposes, antibacterial hand lotions; antibiotic preparations; antiviral and anti-infectious preparations, namely, antivirals, pharmaceutical products for the treatment of infectious diseases or viral infections; anti-inflammatory...
leapfrog

General Information


Serial Number79353163
Word MarkLEAPFROG
Filing DateWednesday, July 6, 2022
Status700 - REGISTERED
Status DateTuesday, April 16, 2024
Registration Number7357663
Registration DateTuesday, April 16, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements


Goods and ServicesPharmaceuticals for the prevention and treatment of iron disorders, allergies, skin disorders, immune system related diseases and disorders; Pharmaceuticals preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, herpetological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders in domestic animals; Antibacterial preparations for human absorption and consumption, namely, antibacterial pharmaceuticals, antibacterial spray, antibacterial substance for medical purposes, antibacterial hand lotions; antibiotic preparations; antiviral and anti-infectious preparations, namely, antivirals, pharmaceutical products for the treatment of infectious diseases or viral infections; anti-inflammatory preparations; pharmaceutical preparations for dermatological uses; medicinal preparations for slimming purposes; antiseptics, disinfectants; diagnostic preparations for medical purposes; natural remedies in the nature of preparations for the treatment of gastrointestinal conditions, hormonal and chemical imbalance, immune system related diseases and disorders, sleep disorders; herbal tinctures for medical purposes; herbal health preparations and remedies, namely, herbal supplements, remedies in the form of chewable tablets, for boosting energy, boosting immune system, promoting healthy skin; cough remedies, namely, cough syrups, cough lozenges, cough treatment preparations; remedies for colds, namely, preparations for treating colds; pharmaceutical preparations derived from natural substances for remedial purposes, namely, for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, herpetological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nasal sprays for medical purposes, nasal rinse, nasal drops for treatment of allergies, nasal decongestants; allopathic remedies, namely, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; homeopathic remedies, namely, homeopathic supplements, homeopathic pharmaceuticals for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genito-urinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; herbal tea preparations for medicinal use; herbal oils being herbal extracts adapted for medical use, herbs for medicinal uses; roots for medicinal purposes; peels for medicinal purposes in the nature of medicated skin care preparations; medicated hair lotions and shampoos; medicated skin care lotions and creams; dietary and nutritional supplements for human beings; mineral nutritional supplements; vitamin supplements; dietetic substances, namely, preparations, chews, tablets adapted for medical use; food for babies and infants; infant formula; dietary fibre for treating constipation, aiding digestion; protein powder dietary supplements; medical plasters

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLeapfrog Remedies Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameLeapfrog Remedies Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameLeapfrog Remedies Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, October 20, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, October 27, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, October 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 4, 2022APPLICATION FILING RECEIPT MAILED
Thursday, April 20, 2023ASSIGNED TO EXAMINER
Tuesday, April 25, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 26, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 9, 2023REFUSAL PROCESSED BY MPU
Friday, June 9, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 4, 2023REFUSAL PROCESSED BY IB
Friday, December 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 10, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, January 30, 2024NOTIFICATION PROCESSED BY IB
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 20, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 20, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, April 8, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, April 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, July 17, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, October 19, 2024FINAL DISPOSITION PROCESSED
Saturday, October 19, 2024FINAL DISPOSITION NOTICE SENT TO IB
Saturday, November 9, 2024FINAL DECISION TRANSACTION PROCESSED BY IB